glp-1 reactive hypoglycemia after gastric bypass: An emerging complication Reactive Hypoglycaemia After Bariatric Surgery

Even if it thaws and looks clear, it will likely not work

Ellis in a TikTok video

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease

GLP-1 receptor agonist dosing for weight loss ranges widely across individuals, typically starting at 0.25mg weekly and titrating upward based on tolerability and response

The concurrent engagement of all three receptors is hypothesised to produce complementary metabolic effects in pre-clinical models: GLP-1R activation is associated with glucose regulation and appetite modulation, GIPR activation with potentiation of GLP-1mediated responses, and GcgR activation with energy expenditure and hepatic lipid metabolism in laboratory settings